RecallDepth
Class II Ongoing

Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-count bottles (NDC 0378-1819-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

This recall is currently active, issued December 18, 2024. It was issued by Viatris Inc.

Company
Viatris Inc
Recall Initiated
November 18, 2024
Posted
December 18, 2024
Recall Number
D-0122-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
55,032 bottles
Firm Location
Canonsburg, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Superpotent Drug and Subpotent Drug: potency failures obtained

Distribution

Nationwide within the United States and Puerto Rico

Lot / Code Info

Lot #: a)8179847, Exp. Date July 2025; b) 3203518, Exp. Date July 2025

More recalls by Viatris Inc

View all recalls by this company →

Other recent Class II Drug recalls